Effect of drug therapy on net cholesterol efflux capacity of HDL-enriched serum in rheumatoid arthritis

BACKGROUND: Patients with rheumatoid arthritis (RA) have increased coronary heart disease (CHD) risk. Some RA therapies may modify this risk, but underlying mechanisms are unclear. HDL’s cholesterol efflux capacity is associated with reduced CHD risk in non-RA populations; however, inflammation may...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Rheumatol
Main Authors: Ormseth, Michelle J., Yancey, Patricia G., Solus, Joseph F., Bridges, S. Louis, Curtis, Jeffrey R., Linton, MacRae F., Fazio, Sergio, Davies, Sean S., Roberts, L. Jackson, Vickers, Kasey C., Kon, Valentina, Stein, C. Michael
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5001900/
https://ncbi.nlm.nih.gov/pubmed/26991245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39675
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados